Hari Krishna Yalamanchili

Hari Krishna Yalamanchili

Auto-generated profile, based on publicly available information

Hari Krishna Yalamanchili

Department of Pediatrics, Baylor College of Medicine, Houston, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Cell Reports
Verified
Journal Article
Open access
YHYi-Chen Hsieh
Yi-Chen Hsieh
CGCaiwei Guo
Caiwei Guo
HYHari K. Yalamanchili
Hari K. Yalamanchili
MAMeasho Abreha
Measho Abreha
RARami Al-Ouran
Rami Al-Ouran
JSJoshua M. Shulman
Joshua M. Shulman
In Alzheimer's disease (AD), spliceosomal proteins with critical roles in RNA processing aberrantly aggregate and mislocalize to Tau neurofibrillary tangles. We test the hypothesis that Tau-spliceosome interactions disrupt pre-mRNA splicing in AD. In human postmortem brain with AD pathology, Tau coimmunoprecipitates with spliceosomal components. In Drosophila, pan-neuronal Tau expression triggers reductions in multiple core and U1-specific spliceosomal proteins, and genetic disruption of these factors, including SmB, U1-70K, and U1A, enhances Tau-mediated neurodegeneration. We further show that loss of function in SmB, encoding a core spliceosomal protein, causes decreased survival, progressive locomotor impairment, and neuronal loss, independent of Tau toxicity. Lastly, RNA sequencing reveals a similar profile of mRNA splicing errors in SmB mutant and Tau transgenic flies, including intron retention and non-annotated cryptic splice junctions. In human brains, we confirm cryptic splicing errors in association with neurofibrillary tangle burden. Our results implicate spliceosome disruption and the resulting transcriptome perturbation in Tau-mediated neurodegeneration in AD.

21 January 2019 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
DSDDD study
DDD study
WZWenjun Zhou
Wenjun Zhou
Yanlin HeYanlin He
Yanlin He
ARAtteeq U Rehman
Atteeq U Rehman
YKYan Kong
Yan Kong
ZSZheng Sun
Zheng Sun

1 January 2017 in Cellular and Molecular Gastroenterology and Hepatology
Verified
Journal Article
Open access
YLYuan-Hung Lo
Yuan-Hung Lo
ECEunah Chung
Eunah Chung
ZLZhaohui Li
Zhaohui Li
YWYing-Wooi Wan
Ying-Wooi Wan
MMMaxime M. Mahe
Maxime M. Mahe
NSNoah F. Shroyer
Noah F. Shroyer
The transcription factor atonal homolog 1 (ATOH1) controls the fate of intestinal progenitors downstream of the Notch signaling pathway. Intestinal progenitors that escape Notch activation express high levels of ATOH1 and commit to a secretory lineage fate, implicating ATOH1 as a gatekeeper for differentiation of intestinal epithelial cells. Although some transcription factors downstream of ATOH1, such as SPDEF, have been identified to specify differentiation and maturation of specific cell types, the bona fide transcriptional targets of ATOH1 still largely are unknown. Here, we aimed to identify ATOH1 targets and to identify transcription factors that are likely to co-regulate gene expression with ATOH1. We used a combination of chromatin immunoprecipitation and messenger RNA-based high-throughput sequencing (ChIP-seq and RNA-seq), together with cell sorting and transgenic mice, to identify direct targets of ATOH1, and establish the epistatic relationship between ATOH1 and SPDEF. By using unbiased genome-wide approaches, we identified more than 700 genes as ATOH1 transcriptional targets in adult small intestine and colon. Ontology analysis indicated that ATOH1 directly regulates genes involved in specification and function of secretory cells. De novo motif analysis of ATOH1 targets identified SPDEF as a putative transcriptional co-regulator of ATOH1. Functional epistasis experiments in transgenic mice show that SPDEF amplifies ATOH1-dependent transcription but cannot independently initiate transcription of ATOH1 target genes. This study unveils the direct targets of ATOH1 in the adult intestines and illuminates the transcriptional events that initiate the specification and function of intestinal secretory lineages.

1 September 2017 in Current Protocols in Bioinformatics
Verified
Journal Article
Open access
PDF file
HYHari Krishna Yalamanchili
Hari Krishna Yalamanchili
YWYing-Wooi Wan
Ying-Wooi Wan
ZLZhandong Liu
Zhandong Liu
RNA sequencing (RNA‐seq) is a high‐throughput technology that provides unique insights into the transcriptome. It has a wide variety of applications in quantifying genes/isoforms and in detecting non‐coding RNA, alternative splicing, and splice junctions. It is extremely important to comprehend the entire transcriptome for a thorough understanding of the cellular system. Several RNA‐seq analysis pipelines have been proposed to date. However, no single analysis pipeline can capture dynamics of the entire transcriptome. Here, we compile and present a robust and commonly used analytical pipeline covering the entire spectrum of transcriptome analysis, including quality checks, alignment of reads, differential gene/transcript expression analysis, discovery of cryptic splicing events, and visualization. Challenges, critical parameters, and possible downstream functional analysis pipelines associated with each step are highlighted and discussed. This unit provides a comprehensive understanding of state‐of‐the‐art RNA‐seq analysis pipeline and a greater understanding of the transcriptome. © 2017 by John Wiley & Sons, Inc.

7 October 2016 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
QTQiumin Tan
Qiumin Tan
HYHari Krishna Yalamanchili
Hari Krishna Yalamanchili
JPJeehye Park
Jeehye Park
AMAntonia De Maio
Antonia De Maio
HLHsiang-Chih Lu
Hsiang-Chih Lu
HZHuda Y. Zoghbi
Huda Y. Zoghbi
Splicing regulation is an important step of post-transcriptional gene regulation. It is a highly dynamic process orchestrated by RNA-binding proteins (RBPs). RBP dysfunction and global splicing dysregulation have been implicated in many human diseases, but the in vivo functions of most RBPs and the splicing outcome upon their loss remain largely unexplored. Here we report that constitutive deletion of Rbm17, which encodes an RBP with a putative role in splicing, causes early embryonic lethality in mice and that its loss in Purkinje neurons leads to rapid degeneration. Transcriptome profiling of Rbm17-deficient and control neurons and subsequent splicing analyses using CrypSplice, a new computational method that we developed, revealed that more than half of RBM17-dependent splicing changes are cryptic. Importantly, RBM17 represses cryptic splicing of genes that likely contribute to motor coordination and cell survival. This finding prompted us to re-analyze published datasets from a recent report on TDP-43, an RBP implicated in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), as it was demonstrated that TDP-43 represses cryptic exon splicing to promote cell survival. We uncovered a large number of TDP-43-dependent splicing defects that were not previously discovered, revealing that TDP-43 extensively regulates cryptic splicing. Moreover, we found a significant overlap in genes that undergo both RBM17- and TDP-43-dependent cryptic splicing repression, many of which are associated with survival. We propose that repression of cryptic splicing by RBPs is critical for neuronal health and survival. CrypSplice is available at www.liuzlab.org/CrypSplice.

1 October 2018 in Cell Reports
Verified
Journal Article
Open access
AMAntonia De Maio
Antonia De Maio
HYHari Krishna Yalamanchili
Hari Krishna Yalamanchili
CACarolyn J. Adamski
Carolyn J. Adamski
VGVincenzo A. Gennarino
Vincenzo A. Gennarino
ZLZhandong Liu
Zhandong Liu
HZHuda Y. Zoghbi
Huda Y. Zoghbi
RNA splicing entails the coordinated interaction of more than 150 proteins in the spliceosome, one of the most complex of the cell's molecular machines. We previously discovered that the RNA-binding motif protein 17 (RBM17), a component of the spliceosome, is essential for survival and cell maintenance. Here, we find that it interacts with the spliceosomal factors U2SURP and CHERP and that they reciprocally regulate each other's stability, both in mouse and in human cells. Individual knockdown of each of the three proteins induces overlapping changes in splicing and gene expression of transcripts enriched for RNA-processing factors. Our results elucidate the function of RBM17, U2SURP, and CHERP and link the activity of the spliceosome to the regulation of downstream RNA-binding proteins. These data support the hypothesis that, beyond driving constitutive splicing, spliceosomal factors can regulate alternative splicing of specific targets.